FDA approves first new sunscreen ingredient in two decades
The U.S. Food and Drug Administration (FDA) has approved bemotrizinol (BEMT) for use in over-the-counter sunscreen products.
Jun 10, 2026
0
8
The U.S. Food and Drug Administration (FDA) has approved bemotrizinol (BEMT) for use in over-the-counter sunscreen products.
Jun 10, 2026
0
8
A research consortium has established a new framework to identify and catalog senescent cells—cells that stop dividing but remain active in the body. Because senescent cells accumulate with age and are thought to contribute ...
Jun 11, 2026
0
8
In 2022, about 149 million children younger than 5 worldwide suffered from childhood stunting. A critical marker of chronic undernutrition, stunting is more than a metric of physical height. It represents a lifelong constraint ...
Jun 10, 2026
0
8
People with mild cognitive impairment (MCI) are at higher risk of developing dementia. Indeed, many of them experience a gradual decline in cognitive performance over time. Smartphone- or tablet-based memory tests can capture ...
Jun 10, 2026
0
8
Northwestern Medicine scientists have identified a safety concern associated with GLP-1 drugs. Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure ...
Jun 13, 2026
0
8
A comprehensive multi-cancer study by researchers at The University of Texas MD Anderson Cancer Center has revealed that cancer cells within tumors are genetically diverse, yet all carry the same core genetic changes that ...
17 hours ago
0
7
Researchers at Kanazawa University have identified a previously unrecognized mechanism by which structural changes in the cerebellum influence social behavior. The study demonstrates that disruption of specialized extracellular ...
Jun 12, 2026
0
7
In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine ...
Jun 14, 2026
0
7
UC San Francisco researchers have developed a new form of deep brain stimulation (DBS) that adjusts in real time as a person walks, helping improve gait and reduce falls in people with Parkinson's disease.
Jun 15, 2026
0
7
A new study from Penn State College of Medicine, to be presented at the SLEEP 2026 annual meeting, found that excessive daytime sleepiness is associated with higher odds of both prevalent and incident hypertension, and taking ...
Jun 10, 2026
0
7